People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NeuroVive Pharmaceutical AB | — | Pharmaceuticals | Series A | $7.5M | $231.1M | 2015 |
Mikael Bronnegard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mikael Bronnegard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jan Nilsson | 1 | 2 |
| Helmuth Malm Von Moltke | 1 | 1 |
| Helena Malm Levander | 1 | 1 |
| Catharina Johansson | 1 | 1 |
| Arne Malm Ferstad | 1 | 1 |
| Marcus Malm Keep | 1 | 1 |
| Carl Fredrick Olsson | 1 | 1 |
| Boel Malm Flodgren | 1 | 1 |
| Anna Malm Bernsten | 1 | 1 |
| Eskil Elmer | 1 | 1 |
| Gregory Batcheller | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.